Prime Medicine, Inc. · NASDAQ:PRME
T. Rowe Price Investment Management, Inc. reported a 5.30% stake in Prime Medicine, Inc. (Schedule 13G)
Event Sep 30, 2025 · Filed Nov 14, 2025
T. Rowe Price Investment Management, Inc. reported a 5.30% stake in Prime Medicine, Inc., 9,236,955 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G).
- Stake
- 5.30%
- Shares
- 9,236,955
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Investment Management, Inc. | 5.30% | 9,236,955 |
Source
Related
- Prime Medicine, Inc.
- T. Rowe Price Investment Management, Inc.
- Prime Medicine, Inc. shareholders
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Feb 17, 2026
- Schedule 13G/A · Alphabet Holdings LLC · Nov 12, 2025
- Schedule 13G/A · FMR LLC · Nov 5, 2025
- Schedule 13D/A · ARCH Venture Fund X, L.P. · Aug 11, 2025
- Schedule 13G/A · Newpath Partners, L.P. · Feb 14, 2025